Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ototoxicity × Chemoradiotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Rectal Neoplasms 9 Esophageal Neoplasms 6 Oropharyngeal Neoplasms 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Non-Small-Cell Lung 4 Head and Neck Neoplasms 3 Nasopharyngeal Carcinoma 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1 Sinonasal Squamous Cell Carcinoma 1 Rectal Malignant Neoplasms 1 Radiation Injuries 1 Postoperative Complications 1 Pathologic Complete Response 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ototoxicity 1 Neoplasms 1 Myelosuppression 1 Mouth Neoplasms 1 Margins of Excision 1 Malignant Tumor of Lacrimal Drainage Structure 1 Lung Neoplasms 1 Low Anterior Resection Syndrome 1 Locally Advanced Hypopharyngeal Carcinoma 1 Locally Advanced Cervical Cancer 1

Interventions

tempol 1 Radiotherapy 1 Radiosurgery 1 Drug Therapy 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡